- Home
- UONE vs UNCY Comparison
UONE vs UNCY Comparison
Compare UONE & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- UNCY
- Stock Information
- Founded
- UONE 1980
- UNCY 2016
- Country
- UONE United States
- UNCY United States
- Employees
- UONE N/A
- UNCY N/A
- Industry
- UONE Broadcasting
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- UONE Consumer Discretionary
- UNCY Health Care
- Exchange
- UONE Nasdaq
- UNCY Nasdaq
- Market Cap
- UONE 74.0M
- UNCY 74.2M
- IPO Year
- UONE N/A
- UNCY 2021
- Fundamental
- Price
- UONE $1.58
- UNCY $4.10
- Analyst Decision
- UONE
- UNCY Strong Buy
- Analyst Count
- UONE 0
- UNCY 4
- Target Price
- UONE N/A
- UNCY $63.75
- AVG Volume (30 Days)
- UONE 11.0K
- UNCY 456.9K
- Earning Date
- UONE 08-13-2025
- UNCY 08-14-2025
- Dividend Yield
- UONE N/A
- UNCY N/A
- EPS Growth
- UONE N/A
- UNCY N/A
- EPS
- UONE N/A
- UNCY N/A
- Revenue
- UONE $411,386,000.00
- UNCY N/A
- Revenue This Year
- UONE N/A
- UNCY N/A
- Revenue Next Year
- UONE N/A
- UNCY $3,131.28
- P/E Ratio
- UONE N/A
- UNCY N/A
- Revenue Growth
- UONE N/A
- UNCY N/A
- 52 Week Low
- UONE $1.23
- UNCY $2.83
- 52 Week High
- UONE $2.23
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- UONE 43.35
- UNCY 43.94
- Support Level
- UONE $1.55
- UNCY $4.15
- Resistance Level
- UONE $1.70
- UNCY $4.40
- Average True Range (ATR)
- UONE 0.08
- UNCY 0.28
- MACD
- UONE -0.00
- UNCY 0.04
- Stochastic Oscillator
- UONE 13.64
- UNCY 30.30
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.